QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
OTCMKTS:NVZMY

Novozymes A/S - NVZMY Stock Forecast, Price & News

$61.94
-1.61 (-2.53%)
(As of 08/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$61.51
$62.29
50-Day Range
$55.87
$63.99
52-Week Range
$55.02
$83.31
Volume
12,741 shs
Average Volume
19,379 shs
Market Capitalization
$14.08 billion
P/E Ratio
N/A
Dividend Yield
0.87%
Price Target
$425.00

Novozymes A/S MarketRank™ Forecast

Analyst Rating
Hold
2.13 Rating Score
Upside/​Downside
586.1% Upside
$425.00 Price Target
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.00mentions of Novozymes A/S in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
6.94%
From $1.73 to $1.85 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.12 out of 5 stars

NVZMY stock logo

About Novozymes A/S (OTCMKTS:NVZMY) Stock

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

Receive NVZMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

NVZMY Stock News Headlines

Here's what to expect from Novozymes A-S (B) Un's earnings
Novozymes A/S ADR - Stock Quote NVZMY
Novozymes A/S (NVZMY)
Group financial statement and annual report for 2021
CE or NVZMY: Which Is the Better Value Stock Right Now?
What Wall Street expects from Novozymes A-S (B) Un's earnings
Interim report for the first nine months of 2021
See More Headlines
Receive NVZMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

NVZMY Company Calendar

Last Earnings
4/29/2020
Today
8/16/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
OTCMKTS:NVZMY
Employees
6,527
Year Founded
2000

Price Target and Rating

Average Stock Price Forecast
$425.00
High Stock Price Forecast
$490.00
Low Stock Price Forecast
$360.00
Forecasted Upside/Downside
+586.1%
Consensus Rating
Hold
Rating Score (0-4)
2.13
Research Coverage
8 Analysts

Profitability

Net Income
$500.53 million
Pretax Margin
24.83%

Debt

Sales & Book Value

Annual Sales
$2.38 billion
Cash Flow
$2.16 per share
Book Value
$8.51 per share

Miscellaneous

Free Float
N/A
Market Cap
$14.08 billion
Optionable
Not Optionable
Beta
0.59

Social Links


Key Executives

  • Ms. Ester Baiget (Age 51)
    Pres & CEO
    Comp: $2.19M
  • Mr. Lars Green M.Sc. (Age 55)
    MSc, Exec. VP & CFO
    Comp: $2.14M
  • Ms. Graziela Chaluppe dos Santos Malucelli (Age 49)
    COO and Exec. VP of Operations, Supply & Quality
  • Mr. Tobias Cornelius Bjorklund
    Head of Investor Relations
  • Mr. Tue Micheelsen
    VP of Global Sales & Marketing
  • Mr. Morten Enggaard Rasmussen (Age 46)
    Exec. VP of People, Sustainability & Brand
  • Mr. Pedro Luiz Fernandes
    Head of Corp. Affairs & Sustainability - Novozymes Latin America
  • Mr. Anders Lund (Age 49)
    Exec. VP of Consumer Biosolutions
  • Mr. Sebastian Søderberg
    VP and Head of New Bus. Devel. - Incubations & Acquisitions
  • Ms. Tina Sejersgaard Fanoe (Age 53)
    Exec. VP of Agriculture & Industrial Biosolutions













NVZMY Stock - Frequently Asked Questions

Should I buy or sell Novozymes A/S stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novozymes A/S in the last twelve months. There are currently 2 sell ratings, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NVZMY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVZMY, but not buy additional shares or sell existing shares.
View NVZMY analyst ratings
or view top-rated stocks.

What is Novozymes A/S's stock price forecast for 2022?

8 brokerages have issued twelve-month price targets for Novozymes A/S's shares. Their NVZMY share price forecasts range from $360.00 to $490.00. On average, they predict the company's share price to reach $425.00 in the next twelve months. This suggests a possible upside of 586.1% from the stock's current price.
View analysts price targets for NVZMY
or view top-rated stocks among Wall Street analysts.

How have NVZMY shares performed in 2022?

Novozymes A/S's stock was trading at $83.12 at the beginning of 2022. Since then, NVZMY stock has decreased by 25.5% and is now trading at $61.94.
View the best growth stocks for 2022 here
.

Are investors shorting Novozymes A/S?

Novozymes A/S saw a decrease in short interest during the month of July. As of July 31st, there was short interest totaling 4,700 shares, a decrease of 48.4% from the July 15th total of 9,100 shares. Based on an average trading volume of 33,800 shares, the days-to-cover ratio is presently 0.1 days.
View Novozymes A/S's Short Interest
.

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMY) announced its earnings results on Wednesday, April, 29th. The biotechnology company reported $0.42 earnings per share for the quarter, hitting analysts' consensus estimates of $0.42. The biotechnology company had revenue of $558.75 million for the quarter. Novozymes A/S had a net margin of 19.13% and a trailing twelve-month return on equity of 25.74%.

How often does Novozymes A/S pay dividends? What is the dividend yield for Novozymes A/S?

Novozymes A/S declared a dividend on Tuesday, March 15th. Stockholders of record on Friday, March 18th will be paid a dividend of $0.567 per share on Tuesday, April 5th. This represents a yield of 0.95%. The ex-dividend date of this dividend is Thursday, March 17th.
Read our dividend analysis for NVZMY
.

Is Novozymes A/S a good dividend stock?

Novozymes A/S (OTCMKTS:NVZMY) pays an annual dividend of $0.55 per share and currently has a dividend yield of 0.87%.
Read our dividend analysis for NVZMY.

What is Novozymes A/S's stock symbol?

Novozymes A/S trades on the OTCMKTS under the ticker symbol "NVZMY."

How do I buy shares of Novozymes A/S?

Shares of NVZMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novozymes A/S's stock price today?

One share of NVZMY stock can currently be purchased for approximately $61.94.

How much money does Novozymes A/S make?

Novozymes A/S (OTCMKTS:NVZMY) has a market capitalization of $14.08 billion and generates $2.38 billion in revenue each year.

How many employees does Novozymes A/S have?

The company employs 6,527 workers across the globe.

Does Novozymes A/S have any subsidiaries?
The following companies are subsidiares of Novozymes A/S: Allopartis, Beta Renewables S.p.A., Delta Biotechnology, Earth BioSciences, Grundejerforeningen Hallas Park, Grundejerforeningen Smørmosen, Iogen Bio-Products, MagnaBioAnalytics LLC, Microbiogen PTY Ltd., Natural Industries, Novozymes (China) Biotechnology Co. Ltd., Novozymes (China) Investment Co. Ltd., Novozymes (Shenyang) Biologicals Co. Ltd., Novozymes (Thailand) Limited, Novozymes Australia Pty. Ltd., Novozymes Belgium BVBA, Novozymes BioAg A/S, Novozymes BioAg Inc., Novozymes BioAg Limited, Novozymes BioAg Productos Para Agricultura Ltda., Novozymes BioAg S.A., Novozymes Bioindustrial A/S, Novozymes Bioindustrial China A/S, Novozymes Biologicals Inc., Novozymes Biopharma DK A/S, Novozymes Blair Inc., Novozymes Canada Limited, Novozymes Deutschland GmbH, Novozymes Enzim Dis Ticaret Ltd., Novozymes France S.A.S, Novozymes Hong Kong Ltd., Novozymes Inc., Novozymes Italia S.r.l., Novozymes Japan Ltd., Novozymes Korea Limited, Novozymes Latin America Ltda., Novozymes Malaysia Sdn. Bhd., Novozymes Mexicana S.A. de C.V., Novozymes Mexico S.A. de C.V., Novozymes Nederland B.V., Novozymes North America Inc., Novozymes RUS LLC, Novozymes Singapore Pte. Ltd., Novozymes South Africa (Pty) Ltd., Novozymes South Asia Pvt. Ltd., Novozymes Spain S.A., Novozymes Sweden AB, Novozymes Switzerland AG, Novozymes Switzerland Holding AG, Novozymes UK Ltd, Novozymes US Inc., OrganoBalance GmbH, Pacific Vet Group-USA, Philom Bios, PrecisionBiotics Group Limited, Qingdao Huayuan Fine Bio-Products, Suzhou Hongda Enzyme Co. Ltd., Sybron Biochemicals, TJ Technologies, and Turfal Indústria e Comércio de Produtos Agrônomicos e Biológicos.
Read More
When was Novozymes A/S founded?

Novozymes A/S was founded in 2000.

How can I contact Novozymes A/S?

Novozymes A/S's mailing address is Krogshoejvej 36, Bagsvaerd G7, 2880. The official website for the company is www.novozymes.com. The biotechnology company can be reached via phone at (454) 446-0000, via email at novozymesir@novozymes.com, or via fax at 45-4446-9999.

This page (OTCMKTS:NVZMY) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.